国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2014年
23期
3595-3598
,共4页
帕利哌酮缓释片%老年期精神分裂症%奋乃静
帕利哌酮緩釋片%老年期精神分裂癥%奮迺靜
파리고동완석편%노년기정신분렬증%강내정
Paliperidone%Elderly schizophrenia%Perphenazine
目的 比较帕利哌酮缓释片与奋乃静片治疗老年期精神分裂症的疗效和安全性.方法 将63例老年期精神分裂症患者随机分为两组,分别予帕利哌酮缓释片和奋乃静片治疗8周,治疗前后采用阳性与阴性症状量表(PANSS)评定疗效、个人和社会功能量表(PSP)评定社会功能改善情况和副反应量表(TESS)观察不良反应.结果 观察组和对照组总有效率分别为84.38%和80.65%,差异无统计学意义(P>0.05).观察组不良反应低于对照组.结论 帕利哌酮缓释片治疗老年精神分裂症疗效较好,安全性高,有利于长期巩固维持治疗.
目的 比較帕利哌酮緩釋片與奮迺靜片治療老年期精神分裂癥的療效和安全性.方法 將63例老年期精神分裂癥患者隨機分為兩組,分彆予帕利哌酮緩釋片和奮迺靜片治療8週,治療前後採用暘性與陰性癥狀量錶(PANSS)評定療效、箇人和社會功能量錶(PSP)評定社會功能改善情況和副反應量錶(TESS)觀察不良反應.結果 觀察組和對照組總有效率分彆為84.38%和80.65%,差異無統計學意義(P>0.05).觀察組不良反應低于對照組.結論 帕利哌酮緩釋片治療老年精神分裂癥療效較好,安全性高,有利于長期鞏固維持治療.
목적 비교파리고동완석편여강내정편치료노년기정신분렬증적료효화안전성.방법 장63례노년기정신분렬증환자수궤분위량조,분별여파리고동완석편화강내정편치료8주,치료전후채용양성여음성증상량표(PANSS)평정료효、개인화사회공능량표(PSP)평정사회공능개선정황화부반응량표(TESS)관찰불량반응.결과 관찰조화대조조총유효솔분별위84.38%화80.65%,차이무통계학의의(P>0.05).관찰조불량반응저우대조조.결론 파리고동완석편치료노년정신분렬증료효교호,안전성고,유리우장기공고유지치료.
Objective To investigate the efficacy and safety of paliperidone and perphenazine tablets in the treatment of eldedy schizophrenia.Methods A total of 63 elderly schizophrenia randomlized into two groups were respectively given Paliperidone or perphenazine for 8 weeks.Clinical effect was evaluated was Positive and Negative Symptom Scale (PANSS),Personal and Social Performance Scale (PSP) and the assessment of adverse drug reaction was evaluated with Traumatic Exposure Severity Scale (TESS).Results The total effective rate was respectively 84.38% or 80.65%.There were no significant differences in the clinical effect between the two groups.And side effects of Paliperidone were less than perphenazine.Conclusion Paliperidone has good efficacy and high safety in the treatment of elderly schizophrenia patients.So it is beneficial to maintained treatment.